In vitro selection of Streptococcus pneumoniae strains with decreased susceptibility to beta-lactams and macrolides

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 10, 1996, Pages 735-746

  Carsenti Etesse, Hélène ^a,b   Roger, Pierre Marie ^a   Dunais, Brigitte ^a   Mancini, Géraldine ^a   Thabaut, André ^a   Dellamonica, Pierre ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFUROXIME; DIRITHROMYCIN; MACROLIDE; PENICILLIN G; ROXITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; EPIDEMIOLOGY; GENETIC SELECTION; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE;

EID: 0029805153     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80079-8     Document Type: Article

References (23)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clin Infect Dis. 1992;15:77-83.
2. Klugman KP. Pneumococcal resistance to antibiotics. Clinical Microbiol Rev. 1990;3:171-196.
3. Markiewicz Z, Tomasz A. Variation in penicillin-binding protein patterns of penicillin-resistant clinical isolates of pneumococci. J Clin Microbiol. 1989;27:405-410.
4. Hakenbeck R, Briese T, Chalkley L, et al. Antigenic variation of penicillin-binding proteins from penicillin-resistant clinical strains of Streptococcus pneumoniae. J Infect Dis. 1993;164:313-319.
5. Laible G, Hakenbeck R. Penicillin-binding proteins in β-lactam resistant laboratory mutants of Streptococcus pneumoniae. Mol Microbiol. 1987;1:355-363.
6. Henderson FW, Gilligan PH, Walt K, Goff DA. Nasopharyngeal carriage of antibiotic resistant pneumococci by children in group day care. J Infect Dis. 1988;57:256-263.
7. Ford KL, Mason EO, Sheldon L, et al. Factors associated with middle ear isolates of Streptococcus pneumoniae resistant to penicillin in a children's hospital. J Pediatr. 1991;119:941-944.
8. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis. 1992;166:1346-1353.
9. Baquero F. Streptococcus pneumoniae: Etat actuel de la sensibilité aux antibiotiques en Espagne et relation avec la consommation d'antibiotiques. La lettre de l'infectiologue. 1991;VI:420-422.
10. Moreillon P, Tomasz A. Penicillin resistance and defective lysis in clinical isolates of pneumococci: Evidence for two kinds of antibiotic pressure operating in the clinical environment. J Infect Dis. 1988;157:1150-1157.
11. Carsenti-Etesse H, Durant J, De Salvador F, et al. In-vitro development of resistance to β-lactam antibiotics in Streptococcus pneumoniae. J Antimicrob Chemother. 1995;36:1058-1062.
12. Marty N, Agueda L, Carratala V, Chabanon G. Evaluation de la méthode spiral pour déterminer la CMI de divers antibiotiques. Pathol Biol. 1994;42:448-453.
13. Acar J, Bergogne-Berezin E, Brogard JM, et al. Communiqué 1993 du Comité l'Antibiogramme de la Société Française de Microbiologie. Société d'Edition de l'Association d'Enseignement Médical des Hôpitaux de Paris. Pathol Biol. 1993;41:741-748.
14. National Committee for Clinical Laboratory Standards. Development of interpretative criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. Fifth Information Supplement NCCLS Document. M100-S4. Villanova, Pa: 1993.
15. Sifaoui F, Kitzis MD, Gutmann L. Selection of one step resistant mutants of Streptococcus pneumoniae by different oral β-lactam antibiotics. In: Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy; October 4-7, 1994; Orlando, Fla.
16. Tomasz A. Benefit and risk in the beta-lactam antibiotic resistance strategies of Streptococcus pneumoniae and Staphylococcus aureus. Trends Microbiol. 1994;2:380-385.
17. Williamson R, Hakenbeck R, Tomasz A. In vivo interaction of β-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980;18:629-637.
18. Porter B, Irizarry I, Massie L. Cross resistance to macrolides among Streptococcus pneumoniae. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 7-20, 1995; San Francisco, Calif.
19. Nava JM, Bella F, Lite JG. Predictive factors for invasive disease to penicillin-resistant Streptococcus pneumoniae: A population-based study. Clin Infect Dis. 1994;19:884-890.
20. Garcia-Leoni ME, Cercenado E, Rodano P. Susceptibility of Streptococcus pneumoniae to penicillin: A prospective microbiological and clinical study. Clin Infect Dis. 1992;14:427-435.
21. Geslin P, Fremaux A, Sissia G, et al. Epidemiologie de la résistance aux antibiotiques de Streptococcus pneumoniae en France. Réseau National de Surveillance (1993-1994). Med Mal Infect. 1994;24(Spécial):948-961.
22. Verhaegen J, Glupczynski Y, Verbist L, et al. Capsular types and antibiotic sensitivity of pneumococci isolated from patients with serious infections in Belgium 1980 to 1988. Eur J Clin Microbiol Infect Dis. 1990;9:390-395.
23. Marton A. Pneumococcal antimicrobial resistance: The problem in Hungary. Clin Infect Dis. 1992;15:106-111.